首诊鼻咽癌内镜手术的治疗进展

doi:10.6040/j.issn.1673-3770.0.2020.493

摘要/Abstract

摘要： 鼻咽癌发病率居头颈部肿瘤的首位。治疗方式首选以放疗为主的综合治疗，如诱导化疗、同期化疗、分子靶向治疗、手术等。随着内镜技术及鼻颅底手术在临床的开展以及鼻咽癌的早期诊断的改进，鼻咽癌治疗方式得到了新的发展，头颈外科医生逐渐将内镜微创的手术理念应用于首诊鼻咽癌患者，目的在于提高患者生活质量以及生存率。将对近年来首诊鼻咽癌内镜微创手术治疗现状及进展进行阐述。

关键词: 鼻咽癌, 鼻颅底手术, 内镜, 鼻腔鼻窦恶性肿瘤, 鼻颅底肿瘤

Abstract: Nasopharyngeal carcinoma(NPC)ranks first among head and neck tumors in terms of incidence. Radiotherapy is the first choice modality for treatment, although simultaneous chemotherapy, induced chemotherapy, molecular targeted therapy, surgery, and other comprehensive treatments are also feasible. With the development of endoscopic techniques and nasocranial base surgery in clinical practice, the early diagnosis and treatment of nasopharyngeal carcinoma have recently advanced. Head and neck surgeons have gradually applied the minimally invasive endoscopic surgery concept to the first diagnosis of nasopharyngeal carcinoma, with the purpose of improving the quality of life and survival rate of patients. In this paper, the status and progress of minimally invasive endoscopic surgery for the first nasopharyngeal carcinoma in recent years are reviewed.

Key words: Nasopharyngeal carcinoma, First option, Endoscopic, Operative treatment, New technique

中图分类号:

R739.63

周宇翔,,苗北平,卢永田. 首诊鼻咽癌内镜手术的治疗进展[J]. 山东大学耳鼻喉眼学报, 2021, 35(6): 108-112.

ZHOU Yuxiang,MIAO Beiping, LU Yongtian. Treatment progress of endoscopic surgery for first diagnosed nasopharyngeal carcinoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(6): 108-112.

参考文献

[1] 罗秀玲, 金风, 毕婷, 等. TPF方案诱导化疗不同给药方式联合调强放疗治疗局部晚期鼻咽癌的中期疗效及预后分析[J]. 中华放射医学与防护杂志, 2018, 38(8): 595-601. doi:10.3760/cma.j.issn.0254-5098.2018.08.007. LUO Xiuling, JIN Feng, BI Ting, et al. Mid-term efficacy and prognosis of TPF regimen induction chemotherapy combined with IMRT for locally advanced nasopharyngeal carcinoma[J]. Chin J Radiol Med Prot, 2018, 38(8): 595-601. doi:10.3760/cma.j.issn.0254-5098.2018.08.007.
[2] 余洪猛, 孙希才, 宋小乐. 复发性鼻咽癌内镜手术治疗现状[J]. 中国现代神经疾病杂志, 2019, 19(4): 226-231. doi:10.3969/j.issn.1672-6731.2019.04.003. YU Hongmeng, SUN Xicai, SONG Xiaole. Current situation of endoscopic surgery for recurrent nasopharyngeal carcinoma[J]. Chin J Contemp Neurol Neurosurg, 2019, 19(4): 226-231. doi:10.3969/j.issn.1672-6731.2019.04.003.
[3] King WWK, Ku PKM, Mok CO, et al. Nasopharyngectomy in the treatment of recurrent nasopharyngeal carcinoma: a twelve-year experience[J]. Head Neck, 2000, 22(3): 215-222. doi:10.1002/(sici)1097-0347(200005)22: 3<215: aid-hed2>3.0.co;2-b.
[4] 邱前辉, 李娜, 张秋航, 等. 内镜手术治疗首诊局部晚期鼻咽癌的疗效分析[J]. 中华耳鼻咽喉头颈外科杂志, 2017, 52(5): 365-371. doi:10.3760/cma.j.issn.1673-0860.2017.05.009. QIU Qianhui, LI Na, ZHANG Qiuhang, et al. Clinical efficacy of endoscopic nasopharyngectomy for initially diagnosed advanced nasopharyngeal carcinoma[J]. Chin J Otorhinolaryngol Head Neck Surg, 2017, 52(5): 365-371. doi:10.3760/cma.j.issn.1673-0860.2017.05.009.
[5] 王剑祁, 李刚, 韩日, 等. 局部复发性鼻咽癌挽救性手术治疗[J]. 临床耳鼻咽喉头颈外科杂志, 2016,30(22): 1823-1826. doi:10.13201/j.issn.1001-1781.2016.22.023. WANG Jianqi, LI Gang, HAN Ri, et al. Salvage surgical treatment for local recurrent nasopharyngeal cancer[J]. J Clin Otorhinolaryngol Head Neck Surg, 2016,30(22): 1823-1826. doi:10.13201/j.issn.1001-1781.2016.22.023.
[6] 吴双, 郎锦义, 李志琳, 等. 复发性鼻咽癌再次放疗182例临床分析[J]. 四川医学, 2000, 21(3): 199-201. doi:10.16252/j.cnki.issn1004-0501-2000.03.006. WU Shuang, LANG Jinyi, LI Zhilin, et al. Re-irradiation of recurrent nasopharyngeal carcinoma[J]. Sichuan Med J, 2000, 21(3): 199-201. doi:10.16252/j.cnki.issn1004-0501-2000.03.006.
[7] Lee AW, Law SC, Foo W, et al. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence[J]. Int J Radiat Oncol Biol Phys, 1993, 26(5): 773-782. doi:10.1016/0360-3016(93)90491-d.
[8] Yoshizaki T, Wakisaka N, Murono S, et al. Endoscopic nasopharyngectomy for patients with recurrent nasopharyngeal carcinoma at the primary site[J]. Laryngoscope, 2005, 115(8): 1517-1519. doi:10.1097/01.MLG.0000165383.35100.17.
[9] You R, Zou X, Hua YJ, et al. Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1-T3 nasopharyngeal carcinoma-A case-matched comparison[J]. Radiother Oncol, 2015, 115(3): 399-406. doi:10.1016/j.radonc.2015.04.024.
[10] Simo R, Robinson M, Lei M, et al. Nasopharyngeal carcinoma: united kingdom national multidisciplinary guidelines[J]. J Laryngol Otol, 2016, 130(S2): S97-S103. doi:10.1017/S0022215116000517.
[11] 中国抗癌协会鼻咽癌专业委员会,林少俊,陈晓钟, 等.复发鼻咽癌治疗专家共识[J].中华放射肿瘤学志, 2018, 27(1): 16-22. doi:10.3760/cma.j.issn.1004-4221.2018.01.004. nasopharyngeal carcinoma[J]. Laryngoscope, 2007, 117(5): 894-896. doi:10.1097/MLG.0b013e3180381644.
[12] 刘全, 孙希才, 于华鹏, 等. 鼻内镜下鼻咽癌切除术的手术分型[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 39-45. doi: 10.6040/j.issn.1673-3770.1.2019.016. LIU Quan, SUN Xicai, YU Huapeng, et al. Types of endoscopic transnasal nasopharyngectomy for nasopharyngeal carcinoma[J]. J Otolaryngol Ophthalmol Shandong Univ, 2019, 33(2): 39-45. doi: 10.6040/j.issn.1673-3770.1.2019.016.
[13] Liu J, Yu HP, Sun XC, et al. Salvage endoscopic nasopharyngectomy for local recurrent or residual nasopharyngeal carcinoma: a 10-year experience[J]. Int J Clin Oncol, 2017, 22(5):834-842. doi: 10.1007/s10147-017-1143-9.
[14] Chan KCA, Woo JKS, King A, et al. Analysis of plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer[J]. N Engl J Med, 2017, 377(6): 513-522. doi:10.1056/nejmoa1701717.
[15] Ji MF, Huang QH, Yu X, et al. Evaluation of plasma epstein-barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China[J]. Cancer, 2014, 120(9): 1353-1360. doi:10.1002/cncr.28564.
[16] Zhang MX, Li J, Shen GP, et al. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up[J]. Eur J Cancer, 2015, 51(17): 2587-95. doi: 10.1016/j.ejca.2015.08.006.
[17] Su SF, Han F, Zhao C, et al. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone[J]. Int J Radiat Oncol Biol Phys,2012,82(1):327-33. doi: 10.1016/j.ijrobp.2010.09.011.
[18] 司勇锋, 陶仲强, 张政, 等. 手术联合同步放化疗治疗早期鼻咽癌的前瞻性研究[J]. 临床耳鼻咽喉头颈外科杂志, 2012, 26(9): 422-425. doi: 10.3969/j.issn.1672-5085.2012.48.323. SI Yongfeng, TAO Zhongqiang, ZHANG Zheng, et al. A prospective study of surgery combined with concurrent radiochemotherapy in the treatment of patients with early stage nasopharyngeal carcinoma[J]. Journal of Clinical Otorhinolaryngology, 2012, 26(9): 422-425. doi: 10.3969/j.issn.1672-5085.2012.48.323.
[19] Liu YP, Xie YL, Zou X, et al. Techniques of endoscopic nasopharyngectomy for localized stage I nasopharyngeal carcinoma[J]. Head Neck, 2020, 42(4): 807-812. doi:10.1002/hed.26090.
[20] Liu YP, Lv X, Zou X, et al. Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma[J]. Cancer Commun(Lond), 2019, 39(1): 75. doi:10.1186/s40880-019-0415-3.
[21] 赵丽娟, 姜彦, 于龙刚, 等. 鼻咽癌内镜手术治疗临床分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 51-56. doi:10.6040/j.issn.1673-3770.0.2019.073. ZHAO Lijuan, JIANG Yan, YU Longgang, et al. Clinical analysis of endoscopic surgery for nasopharyngeal carcinoma[J]. J Otolaryngol Ophthalmol Shandong Univ, 2019, 33(2): 51-56. doi:10.6040/j.issn.1673-3770.0.2019.073.
[22] Weng JJ, Wei JZ, Li M, et al. Effects of surgery combined with chemoradiotherapy on short- and long-term outcomes of early-stage nasopharyngeal carcinoma[J]. Cancer Manag Res, 2020, 12: 7813-7826. doi:10.2147/CMAR.S262567.
[23] Huang Y, Qiu QH. Endoscopic surgery for early-stage nasopharyngeal carcinoma: a justified initial option[J]. Acta Otolaryngol, 2017, 137(11): 1194-1198. doi:10.1080/00016489.2017.1351041.
[24] Lee CC, Huang TT, Lee MS, et al. Clinical application of tumor volume in advanced nasopharyngeal carcinoma to predict outcome[J]. Radiat Oncol, 2010, 5: 20. doi:10.1186/1748-717x-5-20.
[25] Wu Z, Su Y, Zeng RF, et al. Prognostic value of tumor volume for patients with nasopharyngeal carcinoma treated with concurrent chemotherapy and intensity-modulated radiotherapy[J]. J Cancer Res Clin Oncol, 2014, 140(1): 69-76. doi:10.1007/s00432-013-1542-x.
[26] 邱前辉, 陈卓. 鼻内镜手术治疗首诊局部晚期鼻咽癌及放疗后严重并发症的作用[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 17-20. doi:10.6040/j.issn.1673-3771.1.2019.012. QIU Qianhui, CHEN Zhuo. Endoscopic surgery for the treatment of locally advanced nasopharyngeal carcinoma and serious complications after radio-therapy[J]. J Otolaryngol Ophthalmol Shandong Univ, 2019, 33(2): 17-20. doi:10.6040/j.issn.1673-3771.1.2019.012.
[27] 邱前辉, 高俊潇. 鼻咽癌外科治疗的历史与现状及展望[J]. 中国耳鼻咽喉颅底外科杂志, 2020, 26(5): 473-477. doi:10.11798/j.issn.1007-1520.202005001. QIU Qianhui, GAO Junxiao. The history, current situation and prospect of surgery of nasopharyngeal carcinoma[J]. Chin J Otorhinolaryngol - Skull Base Surg, 2020, 26(5): 473-477. doi:10.11798/j.issn.1007-1520.202005001.
[28] Ozer E, Waltonen J. Transoral robotic nasopharyngectomy: a novel approach for nasopharyngeal lesions[J]. Laryngoscope, 2008, 118(9): 1613-1616. doi:10.1097/MLG.0b013e3181792490.
[29] Wei WI, Ho WK. Transoral robotic resection of recurrent nasopharyngeal carcinoma[J]. Laryngoscope, 2010, 120(10): 2011-2014. doi:10.1002/lary.21059.
[30] Tsang RK, To VS, Ho AC, et al. Early results of robotic assisted nasopharyngectomy for recurrent nasopharyngeal carcinoma[J]. Head Neck, 2015, 37(6): 788-793. doi:10.1002/hed.23672.
[31] Chan JYW, Wei WI. Three-dimensional endoscopy for endoscopic salvage nasopharyngectomy: Preliminary report of experience[J]. Laryngoscope, 2018, 128(6): 1386-1391. doi:10.1002/lary.26993.

相关文章 15

[1]	张国民,王茂华,高松,吴文斌,虞幼军. 持续灌流模式耳内镜下粘连性中耳炎手术疗效分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 16-19.
[2]	林小雪,林葆睿,李佩珊,卢标清. 电子鼻咽镜联合窄带成像技术在鼻咽癌中医辨证中的应用[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 40-46.
[3]	卢朝阳, 翟兆雪, 王慧康, 邵丽婷, 张宇. 新冠肺炎治疗引发糖尿病酮症酸中毒合并鼻眶脑型毛霉菌病1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 90-94.
[4]	程卓, 梁辉, 邢鲁民. 深度学习技术在咽喉内镜应用中的研究进展及前景分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 112-119.
[5]	李帅,黄春燕,常明章. 鼻内镜下鼻中隔软骨尾端偏曲矫正术的临床效果分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 65-70.
[6]	刘梓琪,黄佳丽,汪李琴,陈曦,张立庆,周涵. 窄带成像内镜联合嗓音声学分析在声带白斑鉴别诊断中的价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 87-96.
[7]	王盛,李银丹,杨金姬. microRNA在鼻咽癌中的作用及其研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 125-131.
[8]	邱前辉,肖旭平,杨钦泰,叶菁,邓泽义,王德生,谭国林,蒋卫红,卢永田,唐隽,石照辉,邓晓聪,刘遗斌,王跃武,段传志,杜德坤,白小欣,陈文伙,莫立根,蔡楚伟,曾鹏,何旭英,杨一梅,赵洲洋,陈健龙,赵充,林志雄,李先明,李曙平,陈冬平,陈勇,黄莹,陈春燕,韩非,黄理金,瞿申红. 鼻咽癌治疗后并发颈动脉爆裂综合征的临床处理专家共识[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 1-18.
[9]	王思权,朱洪申,张晓斌,赵洲洋,马跃,杨一梅,黄理金. 放射治疗后鼻咽癌患者单侧颈内动脉栓塞术后脑卒中及颅神经麻痹的相关因素分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 19-25.
[10]	黄巧,任毅,侯涛,廖行伟,朱子昂,詹晓琳,刘盈,尹时华. 鼻咽癌组织中EphB2表达及与临床病理特征的相关性[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 26-30.
[11]	孙春晓,王文晴,岳田,刘济生. 高低累积顺铂剂量同步放化疗治疗鼻咽癌的疗效分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 31-41.
[12]	徐飞,朱光熹,王可心. 基于决策树算法构建鼻咽癌患者放疗后发生放射性口腔黏膜炎风险的预测模型[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 42-48.
[13]	王再兴,唐志元,李定波,石照辉,曾宪海,张秋航. 鼻咽癌放疗后肿瘤复发及颅底骨坏死引起颈内动脉破裂的治疗方案[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 49-58.
[14]	孙芳,谢楚波,邱前辉. 营养指标对鼻咽癌放射性颅底坏死患者创面修复影响的回顾性分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 59-68.
[15]	姜知临,朱瑞楷,邱前辉. 基于影像学对咽旁颈内动脉走行的观察与分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 69-76.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed